Indegene Limited

Indegene Limited (INDGN) is a small-cap Healthcare company valued at ₹14,416 crore operating in Healthcare Research, Analytics & Technology on the NSE and BSE.

Recent price move

Indegene Limited last traded at ₹596.55, modestly up 0.90% on the day.

Recent developments

On 2026-07-31, the company announced a dividend of ₹2.25 per share, effective from the ex-date. In the latest quarter, revenue reached ₹1,063 crore, up from ₹761 crore a year earlier, while net profit remained at ₹116 crore.

Financial performance

The company's annual revenue grew 23.7% year-over-year, while net profit declined slightly by -1.4%. In the latest quarter, revenue rose 39.7% compared to the same quarter a year earlier, but net profit was flat at 0.2% growth.

Valuation multiples

The stock trades at 35.7 times earnings, broadly in line with the Healthcare median of 32.0, 4.43 times book value. It yields 0.4%.

Things to watch

The net profit margin narrowed by 2.9 percentage points to 11.4%, reflecting lower profitability. The stock is 4.6% below its 52-week high, indicating a recent pullback from its peak.

Where it stands

The company has shown strong revenue growth over both three and five years, with a 15.0% and 29.4% CAGR respectively. However, net profit margin has declined, and the stock is trading below its 52-week high. The latest quarter's net profit was flat, while revenue surged.

Summarised by DocStoX's model on 2026-10-17 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.